健麾信息收盘上涨1.99%，滚动市盈率154.78倍，总市值27.87亿元

Group 1 - The core viewpoint of the articles highlights the performance and market position of Jianhui Information, which operates in the medical services and pharmaceutical distribution sector, showcasing its growth and challenges in the current market environment [1][2] - As of April 1, Jianhui Information's stock closed at 20.49 yuan, with a PE ratio of 154.78, significantly higher than the industry average of 52.86 [1][2] - The company has a total market capitalization of 2.787 billion yuan, ranking 40th in the medical services industry based on PE ratio [1][2] Group 2 - Jianhui Information reported a revenue of 195 million yuan for the third quarter of 2024, reflecting a year-on-year decrease of 19.07%, while net profit fell by 56.71% to 32.05 million yuan [1] - The company's gross profit margin stands at 57.35%, indicating its ability to maintain profitability despite declining revenues [1] - The company has implemented various intelligent drug management projects in over 800 hospitals across 29 provinces, enhancing its brand recognition and market presence [1]